Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Oral thromboprophylaxis following total hip replacement: the issue of compliance.

Lebel B, Malherbe M, Gouzy S, Parienti JJ, Dutheil JJ, Barrellier MT, Vielpeau C.

Orthop Traumatol Surg Res. 2012 Apr;98(2):186-92. doi: 10.1016/j.otsr.2011.10.010. Epub 2012 Mar 3.

2.

Pharmacoeconomics of dabigatran etexilate for prevention of thromboembolism after joint replacement surgery.

Wolowacz SE.

Expert Rev Pharmacoecon Outcomes Res. 2011 Feb;11(1):9-25. doi: 10.1586/erp.10.89. Review.

PMID:
21351853
3.

Dabigatran etexilate: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.

Burness CB, McKeage K.

Drugs. 2012 May 7;72(7):963-86. doi: 10.2165/11209080-000000000-00000. Review.

PMID:
22564134
4.

Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor.

Stangier J, Clemens A.

Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:9S-16S. doi: 10.1177/1076029609343004. Epub 2009 Aug 19. Review.

PMID:
19696042
5.

Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip or knee surgery: a NICE single technology appraisal.

Holmes M, Carroll C, Papaioannou D.

Pharmacoeconomics. 2012 Feb 1;30(2):137-46. doi: 10.2165/11591590-000000000-00000. Review.

PMID:
22185183
6.

Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty.

Eriksson BI, Friedman RJ.

Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:25S-31S. doi: 10.1177/1076029609340668. Epub 2009 Jul 31. Review.

PMID:
19648146
7.

Dabigatran etexilate for the prophylaxis of venous thromboembolism after hip or knee replacement rationale for dose regimen.

Dahl OE.

Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:17S-24S. doi: 10.1177/1076029609344588. Epub 2009 Aug 19. Review.

PMID:
19696041
8.

Dabigatran etexilate: future directions in anticoagulant treatment.

Schulman S, Reilly PA.

Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:32S-41S. doi: 10.1177/1076029609344199. Epub 2009 Aug 13. Review.

PMID:
19679590
9.

Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.

Stevenson M, Scope A, Holmes M, Rees A, Kaltenthaler E.

Health Technol Assess. 2009 Oct;13 Suppl 3:43-8. doi: 10.3310/hta13suppl3/07. Review.

11.

Thromboprophylaxis in major knee and hip replacement surgery: a review.

Eymin G, Jaffer AK.

J Thromb Thrombolysis. 2012 Nov;34(4):518-25. doi: 10.1007/s11239-012-0751-5. Review.

PMID:
22653706
12.
13.

New oral anticoagulants and outpatient prophylaxis of venous thromboembolism.

Fisher WD.

Am J Manag Care. 2011 Feb;17(1 Suppl):S15-21. Review.

14.

[Prophylaxis of venous thromboembolism in orthopedic surgery. Role of the new anticoagulants].

Guijarro Merino R, Villalobos Sánchez A.

Med Clin (Barc). 2012 Oct;139 Suppl 2:13-8. doi: 10.1016/S0025-7753(12)70036-2. Review. Spanish.

PMID:
23498067
15.

Extended thromboprophylaxis following lower limb arthroplasty: what do the clinical trials mean?

Cohen AT, Khushal A.

Haemostasis. 2000;30 Suppl 2:88-94; discussion 82-3. Review.

PMID:
11251349
16.

Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis.

Neumann I, Rada G, Claro JC, Carrasco-Labra A, Thorlund K, Akl EA, Bates SM, Guyatt GH.

Ann Intern Med. 2012 May 15;156(10):710-9. doi: 10.7326/0003-4819-156-10-201205150-00421. Epub 2012 Mar 12. Review.

PMID:
22412038
17.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
18.

Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal.

Holmes M, Carroll C, Papaioannou D.

Health Technol Assess. 2009 Sep;13 Suppl 2:55-62. doi: 10.3310/hta13suppl2/08. Review.

19.

Recent developments in the use of oral anticoagulants.

Lassen MR.

Expert Opin Pharmacother. 2009 Aug;10(11):1769-81. doi: 10.1517/14656560903042325. Review.

PMID:
19548861
20.

Thromboembolic prophylaxis in orthopedic surgery using dabigatran: an oral direct thrombin inhibitor.

Garza R, Huo MH.

Expert Rev Cardiovasc Ther. 2012 Apr;10(4):423-7. doi: 10.1586/erc.12.15. Review.

PMID:
22458575
Items per page

Supplemental Content

Write to the Help Desk